Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute. At the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results